Celanese Announces Collaboration with Alessa Therapeutics for the Advancement of Oncology Treatments
Celanese Announces Hytrel® Price Increases
Celanese Corporation Reports Full Year 2022 and Fourth Quarter Earnings
Celanese and Mitsui & Co., Ltd. to Form Food Ingredients Joint Venture; Extend Existing Fairway Methanol LLC Joint Venture
Celanese Completes EVA Capacity Expansion at Acetyl Chain Facility in Edmonton
Celanese Announces a Research Agreement with Johns Hopkins University to Advance Sustained Ocular Drug Delivery to the Suprachoroidal Space
Celanese Corporation Declares Quarterly Dividend of $0.70 Per Share
Celanese Expanding Portfolio of Sustainable Products Across Acetyl Chain
Celanese to Hold Fourth Quarter Earnings Conference Call on February 24, 2023
Celanese Corporation Lifts Force Majeure on Acetate Tow Products